Chemoinformaics analysis of 1-METHOXY-4-[(E)-2-(4-METHOXYPHENYL)ETHENYL]BENZENE
Molecular Weight | 240.302 | nRot | 4 |
Heavy Atom Molecular Weight | 224.174 | nRig | 13 |
Exact Molecular Weight | 240.115 | nRing | 2 |
Solubility: LogS | -4.951 | nHRing | 0 |
Solubility: LogP | 4.368 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 2 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 2 | No. of Arom Bond | 12 |
nHA | 2 | APOL | 38.9927 |
nHD | 0 | BPOL | 19.5233 |
QED | 0.755 |
Synth | 1.486 |
Natural Product Likeliness | 0.028 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.997 |
Pgp-sub | 0.002 |
HIA | 0.005 |
CACO-2 | -4.729 |
MDCK | 0.0000167 |
BBB | 0.295 |
PPB | 0.985798 |
VDSS | 0.958 |
FU | 0.0158995 |
CYP1A2-inh | 0.894 |
CYP1A2-sub | 0.966 |
CYP2c19-inh | 0.392 |
CYP2c19-sub | 0.644 |
CYP2c9-inh | 0.309 |
CYP2c9-sub | 0.937 |
CYP2d6-inh | 0.319 |
CYP2d6-sub | 0.951 |
CYP3a4-inh | 0.56 |
CYP3a4-sub | 0.81 |
CL | 10.053 |
T12 | 0.281 |
hERG | 0.926 |
Ames | 0.908 |
ROA | 0.041 |
SkinSen | 0.968 |
Carcinogencity | 0.478 |
EI | 0.963 |
Respiratory | 0.074 |
NR-Aromatase | 0.178 |
Antiviral | No |
Prediction | 0.744655 |